Glenmark Pharma launches Nebzmart GFB & Airz FB Smartules, a fixed-dose triple therapy for COPD. Improves lung function & ...

Making asthma inhalers more affordable— new legislation signed by Governor Hochul will eliminate out of pocket costs for the ...

A new proposal in the New York State Assembly would require health insurance plans to fully cover asthma inhalers with no out ...

Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...

She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...

Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as ...

Glenmark Pharmaceuticals added 1.75% after the company announced launch of Nebzmart GFB Smartules and Glenmark Airz FB Smartules, the world's first nebulized, fixed-dose triple therapy for Chronic ...

Glenmark Pharmaceuticals on Tuesday said it has launched the world's first nebulised, fixed-dose triple therapy ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs and ...

Bangladesh is grappling with a hidden health crisis that thousands endure daily but few fully understand: a rising tide of chronic respiratory diseases, particularly chronic obstructive pulmonary ...

The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world's first nebulised, fixed-dose ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...